196 related articles for article (PubMed ID: 24256146)
1. Bisubstrate UDP-peptide conjugates as human O-GlcNAc transferase inhibitors.
Borodkin VS; Schimpl M; Gundogdu M; Rafie K; Dorfmueller HC; Robinson DA; van Aalten DM
Biochem J; 2014 Feb; 457(3):497-502. PubMed ID: 24256146
[TBL] [Abstract][Full Text] [Related]
2. Thio-Linked UDP-Peptide Conjugates as O-GlcNAc Transferase Inhibitors.
Rafie K; Gorelik A; Trapannone R; Borodkin VS; van Aalten DMF
Bioconjug Chem; 2018 Jun; 29(6):1834-1840. PubMed ID: 29723473
[TBL] [Abstract][Full Text] [Related]
3. Bisubstrate Ether-Linked Uridine-Peptide Conjugates as O-GlcNAc Transferase Inhibitors.
Makwana V; Ryan P; Malde AK; Anoopkumar-Dukie S; Rudrawar S
ChemMedChem; 2021 Feb; 16(3):477-483. PubMed ID: 32991074
[TBL] [Abstract][Full Text] [Related]
4. Substrate and product analogues as human O-GlcNAc transferase inhibitors.
Dorfmueller HC; Borodkin VS; Blair DE; Pathak S; Navratilova I; van Aalten DM
Amino Acids; 2011 Mar; 40(3):781-92. PubMed ID: 20640461
[TBL] [Abstract][Full Text] [Related]
5. Novel bisubstrate uridine-peptide analogues bearing a pyrophosphate bioisostere as inhibitors of human O-GlcNAc transferase.
Ryan P; Shi Y; von Itzstein M; Rudrawar S
Bioorg Chem; 2021 May; 110():104738. PubMed ID: 33667901
[TBL] [Abstract][Full Text] [Related]
6. A small molecule that inhibits OGT activity in cells.
Ortiz-Meoz RF; Jiang J; Lazarus MB; Orman M; Janetzko J; Fan C; Duveau DY; Tan ZW; Thomas CJ; Walker S
ACS Chem Biol; 2015 Jun; 10(6):1392-7. PubMed ID: 25751766
[TBL] [Abstract][Full Text] [Related]
7. O-GlcNAc transferase inhibitors: current tools and future challenges.
Trapannone R; Rafie K; van Aalten DM
Biochem Soc Trans; 2016 Feb; 44(1):88-93. PubMed ID: 26862193
[TBL] [Abstract][Full Text] [Related]
8. Discovery of two non-UDP-mimic inhibitors of O-GlcNAc transferase by screening a DNA-encoded library.
Balsollier C; Bijkerk S; de Smit A; van Eekelen K; Bozovičar K; Husstege D; Tomašič T; Anderluh M; Pieters RJ
Bioorg Chem; 2024 Jun; 147():107321. PubMed ID: 38604018
[TBL] [Abstract][Full Text] [Related]
9. Insights into O-linked N-acetylglucosamine ([0-9]O-GlcNAc) processing and dynamics through kinetic analysis of O-GlcNAc transferase and O-GlcNAcase activity on protein substrates.
Shen DL; Gloster TM; Yuzwa SA; Vocadlo DJ
J Biol Chem; 2012 May; 287(19):15395-408. PubMed ID: 22311971
[TBL] [Abstract][Full Text] [Related]
10. Antibodies and activity measurements for the detection of O-GlcNAc transferase and assay of its substrate, UDP-GlcNAc.
Lefebvre T; Drougat L; Olivier-Van Stichelen S; Michalski JC; Vercoutter-Edouart AS
Methods Mol Biol; 2013; 1022():147-59. PubMed ID: 23765660
[TBL] [Abstract][Full Text] [Related]
11. Structure of human O-GlcNAc transferase and its complex with a peptide substrate.
Lazarus MB; Nam Y; Jiang J; Sliz P; Walker S
Nature; 2011 Jan; 469(7331):564-7. PubMed ID: 21240259
[TBL] [Abstract][Full Text] [Related]
12. Distributive O-GlcNAcylation on the Highly Repetitive C-Terminal Domain of RNA Polymerase II.
Lu L; Fan D; Hu CW; Worth M; Ma ZX; Jiang J
Biochemistry; 2016 Feb; 55(7):1149-58. PubMed ID: 26807597
[TBL] [Abstract][Full Text] [Related]
13. Revealing the conformational dynamics of UDP-GlcNAc recognition by O-GlcNAc transferase via Markov state model.
Tian J; Dong X; Wu T; Wen P; Liu X; Zhang M; An X; Shi D
Int J Biol Macromol; 2024 Jan; 256(Pt 1):128405. PubMed ID: 38016609
[TBL] [Abstract][Full Text] [Related]
14. The active site of O-GlcNAc transferase imposes constraints on substrate sequence.
Pathak S; Alonso J; Schimpl M; Rafie K; Blair DE; Borodkin VS; Albarbarawi O; van Aalten DMF
Nat Struct Mol Biol; 2015 Sep; 22(9):744-750. PubMed ID: 26237509
[TBL] [Abstract][Full Text] [Related]
15. O-GlcNAc transferase invokes nucleotide sugar pyrophosphate participation in catalysis.
Schimpl M; Zheng X; Borodkin VS; Blair DE; Ferenbach AT; Schüttelkopf AW; Navratilova I; Aristotelous T; Albarbarawi O; Robinson DA; Macnaughtan MA; van Aalten DM
Nat Chem Biol; 2012 Dec; 8(12):969-74. PubMed ID: 23103942
[TBL] [Abstract][Full Text] [Related]
16. Versatile O-GlcNAc transferase assay for high-throughput identification of enzyme variants, substrates, and inhibitors.
Kim EJ; Abramowitz LK; Bond MR; Love DC; Kang DW; Leucke HF; Kang DW; Ahn JS; Hanover JA
Bioconjug Chem; 2014 Jun; 25(6):1025-30. PubMed ID: 24866374
[TBL] [Abstract][Full Text] [Related]
17. Uridine diphosphate release mechanism in O-N-acetylglucosamine (O-GlcNAc) transferase catalysis.
She N; Zhao Y; Hao J; Xie S; Wang C
Biochim Biophys Acta Gen Subj; 2019 Mar; 1863(3):609-622. PubMed ID: 30550897
[TBL] [Abstract][Full Text] [Related]
18. Optimised chemical synthesis of 5-substituted UDP-sugars and their evaluation as glycosyltransferase inhibitors.
Tedaldi LM; Pierce M; Wagner GK
Carbohydr Res; 2012 Dec; 364():22-7. PubMed ID: 23147042
[TBL] [Abstract][Full Text] [Related]
19. The conserved threonine-rich region of the HCF-1
Kapuria V; Röhrig UF; Waridel P; Lammers F; Borodkin VS; van Aalten DMF; Zoete V; Herr W
J Biol Chem; 2018 Nov; 293(46):17754-17768. PubMed ID: 30224358
[No Abstract] [Full Text] [Related]
20. O-GlcNAc Transferase: Structural Characteristics, Catalytic Mechanism and Small-Molecule Inhibitors.
Ju Kim E
Chembiochem; 2020 Nov; 21(21):3026-3035. PubMed ID: 32406185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
